Klarigen (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When sprayed into the nose it binds to α‑adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces blood flow to the mucosa, decreasing edema and mucus production, which relieves congestion.

The specific dose of Klarigen is determined by the prescribing healthcare professional based on the patient’s age, condition, and severity of symptoms. Typically, one or two sprays per nostril every 8–10 hours are recommended, but the exact regimen should follow the label instructions or the prescriber’s guidance.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited, and the product is classified as “unknown” for pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should consult their physician before using Klarigen to weigh potential benefits against any possible risks.

To order Klarigen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and assists with any required import documentation.

Klarigen’s active ingredient, Xylometazoline Hydrochloride, belongs to the same class as oxymetazoline and phenylephrine. Compared with phenylephrine, Xylometazoline generally offers a longer duration of action (up to 12 hours) and may cause less rebound congestion when used as directed. All topical decongestants share a risk of over‑use and should be limited to a few days.

Klarigen nasal spray should be stored at room temperature, below 25 °C (77 °F). Keep the bottle in its original packaging, protect it from direct sunlight and moisture, and ensure the cap is tightly closed when not in use. Do not freeze the product, and discard it after the indicated expiry date.

Klarigen is administered as a nasal spray. Before use, gently blow the nose to clear the passages. Hold the bottle upright, insert the tip into one nostril while keeping the other nostril closed, and press the pump to deliver the recommended number of sprays. Repeat in the other nostril if directed, and avoid blowing the nose immediately after application.

The most serious risks of Klarigen include severe hypertension, cardiac arrhythmias, rebound nasal congestion (rhinitis medicamentosa) after prolonged use, and rare allergic reactions such as anaphylaxis or significant nosebleeds. Patients experiencing rapid heart rate, chest pain, severe headache, or signs of an allergic reaction should discontinue use and seek immediate medical attention.

Klarigen should not be used by individuals with known hypersensitivity to Xylometazoline Hydrochloride or any other ingredients in the formulation. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those who have undergone recent nasal surgery unless advised by a physician. Children below the recommended age limit should avoid use as well.